 |
 |
Celadrex is Clinically Proven to WorkCeladrex's all-natural active ingredient Celadrin has undergone various clinical studies which have been published Twice in The Journal of Rheumatology as an effective Arthritis Treatment. Published Results from The Journal of RheumatologyEffect of a Cetylated Fatty Acid Cream on Functional Mobility and Quality of Life of Patients with Osteoarthritis.
Methods - Fourty Patients diagnosed with knee Osteoarthritis were randomly assigned to one of two topical cream treatment groups. Group 1 (cetylated fatty acid) or Group 2 (Placebo Group). Patients were tested on 3 separate occasions (T1) to establish the baseline (T2) 30 mins after initial treatment (T3) after a 30 day treatment of the cream application twice a day. The assessments included knee range of motion, timed up and go from a chair, stair climbing, medial step-down test and the unilateral anterior reach. Results - For the stair climbing ability and the up and go test, significant decreases in time were observed and noted at (T2) and (T3) compared to (T1) in the Cetylated Fatty Acid Group only. These differences were significant between groups. Range of Movement of the knees increased at (T2) and (T3) in the Cetylated Fatty Acid group, where as no difference was observed in the placebo group. For the medial step down test, there were very marked improvement noted at (T2) and (T3) compared to (T1) in Cetylated Fatty Acid Group. For the unilateral anterior reach, significant improvement was observed for both legs in Cetylated Fatty Acid group and only in the left leg for the placebo group. The improvements noted in the CFA group were significantly greater than observed in the placebo group for both legs. 100% of all the patients in the study on Celadrin cream demonstrated a significant benefit when compared to the placebo group. Conclusion - The use of Cetylated Fatty Acid topical cream is an effective Arthritis Treatment for improving knee unilateral balance. Recent Study shows significant improvement in Knee Function and Joint MobilityThe new study, the fourth to be performed on the efficacy of Celadrin in the past six years was conducted by Dr Jay Udani. Dr Udani is the Medical Director of Medicus Research, Medical Director of Intergrative Medicine program at Northbridge Hospital and Assistant Clinical Professor at UCLA/Geffen School of Medicine. The study reported that after eight weeks of taking Celadrin, average walking ability increased 45 percent and participants claimed a 35 percent decrease in knee discomfort. These improvements were significantly better than the results observed in the placebo group and no negative side effects were seen throughout the duration of the study. The study demonstrates that after only two weeks of taking Celadrin, subjects showed significant enhancement of their functional ability and movement, which continued right through until the end of the eight week clinical study, said Dr Udani. The randomised double-blind, placebo controlled study evaluated 93 patients suffering from moderate Knee Osteoarthritis over a 60 day period. Subjects ranged from 40 to 86 years of age and were evaluated before Celadrin was administered and then again after two, four and eight weeks. During each evaluation the subjects were asked to walk for six minutes to measure how far they could travel with their knee discomfort. The individuals who were administered the Celadrin were able to walk an average distance of 1183 feet when the study began. After only two weeks of using Celadrin tablets, the average walking distance increased significantly by 19 percent, or approximately 232 feet. The participants continued to show improvement throughout the study and after eight weeks duration of taking Celadrin, the participants walked an average distance of 1720 feet, which equated to 45 percent more than when they started just two months prior. This study increases the evidence that Celadrin has superior and proven benefits for joint health when compared to other compounds such as Glucosamine, Chondroitin, MSM and Same. Related Links |
Test Objective - To examine the effect of a topical cream consisting of cetylated fatty acids on functional performance in patients diagnosed with Osteoarthritis (OA) of one or both knees.